-
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides
-
Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors—Literature Review and Statement of Experts from Polish Dermatological Society
-
R-DOTAP Adjuvant Elicits Robust and Polyfunctional CD4 T Cells in Response to Flublok Vaccine
Journal Description
Vaccines
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Immunology) / CiteScore - Q1 (Pharmacology (medical))
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 19.2 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the second half of 2023).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Latest Articles
E-Mail Alert
News
Topics
Deadline: 30 June 2024
Deadline: 31 July 2024
Deadline: 31 August 2024
Deadline: 30 September 2024
Conferences
Special Issues
Deadline: 30 June 2024
Deadline: 15 July 2024
Deadline: 31 July 2024
Deadline: 15 August 2024